Using low-dose Theophylline to help manage COPD caused by biomass exposure
Effectiveness of Low-dose Theophylline for the Management of biomass-associated COPD
['FUNDING_OTHER'] · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · NIH-10657669
This study is looking at how well a low dose of Theophylline can help people with COPD caused by exposure to smoke from burning wood or other biomass, focusing on improving their breathing and overall well-being.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (CORAL GABLES, UNITED STATES) |
| Trial ID | NIH-10657669 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of low-dose Theophylline as a treatment for chronic obstructive pulmonary disease (COPD) associated with biomass exposure. The study aims to evaluate how well this medication can improve lung function and overall health in patients suffering from this condition. Patients will be monitored over time to assess the impact of Theophylline on their symptoms and quality of life. The research involves a combination of mentorship and advanced training in clinical trial methodologies to ensure rigorous evaluation of the treatment's effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with COPD related to biomass exposure.
Not a fit: Patients with COPD not associated with biomass exposure or those with other underlying respiratory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new therapeutic option for patients with biomass-associated COPD, potentially improving their lung function and quality of life.
How similar studies have performed: While the use of Theophylline in COPD treatment has been explored, this specific approach focusing on biomass exposure is relatively novel and may provide new insights into its effectiveness.
Where this research is happening
CORAL GABLES, UNITED STATES
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE — CORAL GABLES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SIDDHARTHAN, TRISHUL — UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- Study coordinator: SIDDHARTHAN, TRISHUL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.